Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Kidney360. 2021 Jun 3;2(9):1482-1490. doi: 10.34067/KID.0000362021. eCollection 2021 Sep 30.
Registry-based studies of nephrotic syndrome (NS) may only include a subset of patients with biochemical features of NS. To address this, we compared patients with laboratory-recorded nephrotic proteinuria and hypoalbuminemia to patients with hospital-recorded NS.
We identified adult patients with first-time hospital-recorded NS (inpatients, outpatients, or emergency-room visitors) in the Danish National Patient Registry and compared them with adults with first-time recorded nephrotic proteinuria and hypoalbuminemia in Danish laboratory databases during 2004-2018, defining the date of admission or laboratory findings as the index date. We characterized these cohorts by demographics, comorbidity, medication use, and laboratory and histopathologic findings.
We identified 1139 patients with hospital-recorded NS and 5268 patients with nephrotic proteinuria and hypoalbuminemia; of these, 760 patients were identified in both cohorts. Within 1 year of the first record of nephrotic proteinuria and hypoalbuminemia, 18% had recorded hospital diagnoses indicating the presence of NS, and 87% had diagnoses reflecting any kind of nephropathy. Among patients identified with nephrotic proteinuria and hypoalbuminemia, their most recent eGFR was substantially lower (median of 35 versus 61 ml/min per 1.73 m), fewer underwent kidney biopsies around the index date (34% versus 61%), and the prevalence of thromboembolic disease (25% versus 17%) and diabetes (39% versus 18%) was higher when compared with patients with hospital-recorded NS.
Patients with nephrotic proteinuria and hypoalbuminemia are five-fold more common than patients with hospital-recorded NS, and they have a lower eGFR and more comorbidities. Selective and incomplete recording of NS may be an important issue when designing and interpreting studies of risks and prognosis of NS.
肾病综合征(NS)的基于登记的研究可能仅包括具有 NS 生化特征的患者亚组。为了解决这个问题,我们将实验室记录的肾病性蛋白尿和低白蛋白血症患者与医院记录的 NS 患者进行了比较。
我们在丹麦国家患者登记处中确定了首次记录有医院确诊 NS(住院患者、门诊患者或急诊患者)的成年患者,并将其与 2004-2018 年丹麦实验室数据库中首次记录有肾病性蛋白尿和低白蛋白血症的成年患者进行了比较,将入院日期或实验室检查结果定义为索引日期。我们通过人口统计学、合并症、药物使用以及实验室和组织病理学发现来描述这些队列。
我们确定了 1139 例医院确诊 NS 患者和 5268 例肾病性蛋白尿和低白蛋白血症患者;其中 760 例患者在两个队列中均被识别。在首次记录肾病性蛋白尿和低白蛋白血症后的 1 年内,有 18%的患者记录有 NS 的医院诊断,87%的患者记录有任何类型的肾病。在被识别为肾病性蛋白尿和低白蛋白血症的患者中,其最近的 eGFR 明显较低(中位数分别为 35 与 61 ml/min/1.73 m),在索引日期前后进行肾脏活检的患者较少(34%与 61%),血栓栓塞性疾病(25%与 17%)和糖尿病(39%与 18%)的患病率较高。
肾病性蛋白尿和低白蛋白血症患者比医院确诊 NS 患者多五倍,且 eGFR 较低,合并症更多。在设计和解释 NS 的风险和预后研究时,选择性和不完整记录 NS 可能是一个重要问题。